The Center for Innovation and Translation of Point of Care Technologies for Equitable Cancer Care (CITEC) is a collaboration of bioengineers, oncologists, and international global health partners that will unite a global community of investigators to develop and effectively disseminate point-of-care technologies to detect and treat cancer.
Our collaboration spans three continents and seven organizations, including prominent partnerships within Brazil and Mozambique, Rice360 Institute for Global Health Technologies, Baylor College of Medicine, and The University of Texas MD Anderson Cancer Center.
The Rice University-led collaboration of partners from three continents, received a five-year grant from the National Institutes of Health (NIH) to establish a premier research center in the Texas Medical Center to develop affordable, effective point-of-care (POC) technologies in the advancement of access to care.
POC technologies deliver health care closer to patients, making care timelier and more convenient, which can ultimately lead to better outcomes for patients.
Under the NIH Point of Care Technology Research Network, our mission is to develop affordable, effective point-of-care (POC) technologies that improve early cancer detection in low-resource settings. Point of care technologies deliver health care closer to patients, making care timelier and more convenient, ultimately leading to better health outcomes for the community.
CITEC will identify needed technologies, accelerate their development, evaluate their performance and impact in diverse settings, and train local users and technology developers to create and disseminate more equitable POC technologies with external global partners located in South America and Africa.
Our Partners
|
|
|
|
|
 |
 |
 |
 |
 |
